Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 31 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shilpa Medicare's reported carbon emissions
In 2023, Shilpa Medicare reported total carbon emissions of approximately 36,903,10 kg CO2e from Scope 1, 20,389,900 kg CO2e from Scope 2, and 710,410 kg CO2e from Scope 3. This represents a significant increase in emissions compared to 2022, where the company recorded 1,523,280 kg CO2e in Scope 1, 14,691,660 kg CO2e in Scope 2, and 877,770 kg CO2e in Scope 3. Shilpa Medicare has set ambitious climate commitments, aiming to achieve 100% renewable energy usage by 2030 and to become a net-zero carbon company by 2050. These targets encompass all scopes of emissions, reflecting a comprehensive approach to sustainability. The company's commitment to leading the energy transition is outlined in their long-term strategy, which was initiated in 2023. As of now, there are no specific science-based targets (SBTi) reported, and the emissions data is not cascaded from any parent organization. Shilpa Medicare's proactive stance on climate action positions it as a forward-thinking entity in the pharmaceutical industry, aligning with global sustainability trends.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,523,280 | 0,000,000 |
| Scope 2 | 14,691,660 | 00,000,000 |
| Scope 3 | 877,770 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
